Relationship between Serum Total Bilirubin Level and Cardiac Outcomes in Patients with Isolated Coronary Artery Ectasia

Objective: This study aimed to investigate the association of admission serum bilirubin concentrations with major adverse cardiacevent (MACE) in isolated coronary artery ectasia (ICAE).Methods: This study enrolled 75 consecutive patients (42.7% women with the mean age of 52.3±11.4 years) with ICAE. MACE, basaldemographic, laboratory, angiographic parameters, and admission serum bilirubin concentrations were recorded on follow-upforms. MACE was defined as heart failure, nonfatal myocardial infarction, and cardiovascular death.Results: During follow-up (median 61±11 months), 19 (25.3%) patients experienced MACE. The patients were assigned into twogroups: with MACE and without MACE. Compared with the non-MACE group, the MACE group had significantly lower serum totalbilirubin levels. In addition, when the patients were subcategorized into tertiles of serum bilirubin concentrations, MACE wereidentified in 11 patients in the first tertile, 7 patients in the second tertile, and 1 patient in the third tertile. In the Cox regressionanalyses, serum total bilirubin and C-reactive protein (CRP) were found as independent risk factors for MACE (p

PDF

___

1. Demopoulos V, Olympios C, Fakiolas C, Pissimissis EG, Economides NM, Adamopoulou E, et al. The natural history of aneurysmal coronary artery disease. Heart 1997; 78: 136-41. [Crossref]
2. Swaye PS, Fisher LD, Litwin P, Vignola PA, Judkins MP, Kemp HG, et al. Aneurysmal coronary artery disease. Circulation 1983; 67: 134-8. [Crossref]
3. Boles U, Zhao Y, David S, Eriksson P, Henein MY. Pure coronary ectasia differs from atherosclerosis: morphological and risk factors analysis. Int J Cardiol 2012; 155: 321-3. [Crossref]
4. Markis JE, Joffe CD, Cohn PF, Feen DJ, Herman MV, Gorlin R. Clinical significance of coronary arterial ectasia. Am J Cardiol 1976; 37: 217- 22. [Crossref]
5. Erdoğan T, Kocaman SA, Çetin M, Durakoğlugil ME, Kırbaş A, Canga A, et al. Increased YKL-40 levels in patients with isolated coronary artery ectasia: an observational study. Anadolu Kardiyol Derg 2013; 13: 465-70. [Crossref]
6. Kundi H, Gok M, Kiziltunc E, Cetin M, Cicekcioglu H, Cetin ZG, et al. Relation Between Monocyte to High-Density Lipoprotein Cholesterol Ratio With Presence and Severity of Isolated Coronary Artery Ectasia. Am J Cardiol 2015; 116: 1685-9. [Crossref]
7. Krüger D, Stierle U, Herrmann G, Simon R, Sheikhzadeh A. Exercise-induced. myocardial ischemia in isolated coronary artery ectasias and aneurysms (“dilated coronopathy”). J Am Coll Cardiol 1999; 34: 1461-70. [Crossref]
8. Choi HJS, Luong C, Fung A, Tsang TSM. ST-Elevation Myocardial Infarction in Coronary Ectasia: A Case Report. Diseases 2018; 6: 104. [Crossref]
9. Vítek L. Bilirubin as a predictor of diseases of civilization. Is it time to establish decision limits for serum bilirubin concentrations? Arch Biochem Biophys 2019; 672: 108062. [Crossref]
10. Kang SJ, Kim D, Park HE, Chung GE, Choi SH, Choi SY, et al. Elevated serum bilirubin levels are inversely associated with coronary artery atherosclerosis. Atherosclerosis 2013; 230: 242-8. [Crossref]
11. Turfan M, Duran M, Poyraz F, Yayla C, Akboga MK, Sahinarslan A, et al. Inverse relationship between serum total bilirubin levels and severity of disease in patients with stable coronary artery disease. Coron Artery Dis 2013; 24: 29-32. [Crossref]
12. Demir M, Demir C, Keçeoğlu S. The relationship between serum bilirubin concentration and coronary artery ectasia. Postepy Kardiol Interwencyjnej 2015; 11: 202-5. [Crossref]
13. Yilmaz H, Tayyareci G, Sayar N, Gurkan U, Tangurek B, Asilturk R, et al. Plasma soluble adhesion molecule levels in coronary artery ectasia. Cardiology 2006; 105: 176-81. [Crossref]
14. Xu Y, Yu Q, Yang J, Yuan F, Zhong Y, Zhou Z, et al. Acute Hemodynamic Effects of Remote Ischemic Preconditioning on Coronary Perfusion Pressure and Coronary Collateral Blood Flow in Coronary Heart Disease. Acta Cardiol Sin 2018; 34: 299-306.
15. Fujii T, Sakai K, Kimura M, Nakano M, Ohno Y, Nakazawa G, et al. Coronary flow improvement following unsuccessful primary percutaneous coronary intervention in ST-elevation myocardial infarction with diffuse ectatic coronary artery. Eur Heart J Acute Cardiovasc Care 2017; 6: 623-31. [Crossref]
16. Doi T, Kataoka Y, Noguchi T, Shibata T, Nakashima T, Kawakami S, et al. Coronary Artery Ectasia Predicts Future Cardiac Events in Patients With Acute Myocardial Infarction. Arterioscler Thromb Vasc Biol 2017; 37: 2350-5. [Crossref]
17. Boles U, Wiklund U, David S, Ahmed K, Henein MY. Coronary artery ectasia carries a worse prognosis: a long-term follow-up study. Pol Arch Intern Med 2019; 129: 833-5. [Crossref]
18. Liu Y, Jia SD, Yao Y, Tang XF, Xu N, Jiang L, et al. Impact of high-sensitivity C-reactive protein on coronary artery disease severity and outcomes in patients undergoing percutaneous coronary intervention. J Cardiol 2020; 75: 60-5. [Crossref]
19. Peng X, Peng D, Hu Y, Gang H, Yu Y, Tang S. Correlation of heart rate and blood pressure variability as well as hs-CRP with the burden of stable coronary artery disease. Minerva Cardioangiol 2020; 68: 376- 82. [Crossref]
20. Boles U, Johansson A, Wiklund U, Sharif Z, David S, McGrory S, et al. Cytokine Disturbances in Coronary Artery Ectasia Do Not Support Atherosclerosis Pathogenesis. Int J Mol Sci 2018; 19: 260. [Crossref]
21. Lin JP, Vitek L, Schwertner HA. Serum bilirubin and genes controlling bilirubin concentrations as biomarkers for cardiovascular disease. Clin Chem 2010; 56: 1535-43. [Crossref]
22. Gul M, Uyarel H, Ergelen M, Akgul O, Karaca G, Turen S, et al. Prognostic value of total bilirubin in patients with ST-segment elevation acute myocardial infarction undergoing primary coronary intervention. Am J Cardiol 2013; 111: 166-71. [Crossref]
23. Djoussé L, Levy D, Cupples LA, Evans JC, D’Agostino RB, Ellison RC. Total serum bilirubin and risk of cardiovascular disease in the Framingham offspring study. Am J Cardiol 2001; 87: 1196-200. [Crossref]
24. Chang CC, Hsu CY, Huang PH, Chiang CH, Huang SS, Leu HB, et al. Association of Serum Bilirubin with SYNTAX Score and Future Cardiovascular Events in Patients Undergoing Coronary Intervention. Acta Cardiol Sin 2016; 32: 412-9.
25. Sahin O, Akpek M, Elcik D, Karadavut S, Simsek V, Tulmac M, et al. Bilirubin levels and the burden of coronary atherosclerosis in patients with STEMI. Angiology 2013; 64: 200-4. [Crossref]